Congress Funded Your Grant. It Might Not Matter. Five Ways Federal Dollars Disappear Before They Reach You.

In January 2026, Congress passed and the president signed FY2026 appropriations bills that largely rejected the administration's proposed cuts to science, health, and domestic programs. NIH received $47.2 billion. NSF got $8.75 billion. EPA held at $8.82 billion. On paper, the grant-seeking community had won. The money was there.

Six months later, NIH has awarded 74 percent fewer competitive grants than the average for the same period across the prior four fiscal years. NSF has terminated 1,752 grants worth $1.4 billion. Across the federal enterprise, billions in appropriated funds are sitting in agency accounts while the researchers, nonprofits, and small businesses that were supposed to receive them scramble for alternatives.

This is the lesson of 2026: a Congressional appropriation is necessary but no longer sufficient. Between the moment Congress votes to fund a program and the moment a grantee receives a check, there are now at least five mechanisms that can delay, reduce, or eliminate the money entirely — none of which require Congressional approval. If you depend on federal grants, you need to understand each of them.

1. Impoundment: The Money Sits in the Account, Unspent

The most straightforward mechanism is also the most common. The Office of Management and Budget directs agencies to withhold appropriated funds — sometimes through explicit freeze orders, sometimes through bureaucratic slow-walking that achieves the same result without a formal directive.

As Granted has reported, the gap between what Congress appropriates and what agencies actually disburse has become a defining feature of the current funding landscape. NASA saw over $100 million in FY2025 funds frozen by OMB. NIH is months behind on dispersing the bulk of its FY2026 funding. The Treasury Department's Bureau of the Fiscal Service data shows that actual outlays across multiple domestic agencies are running 15 to 25 percent below the spending rates that would be necessary to fully execute their appropriated budgets by September 30.

The Impoundment Control Act of 1974 was written precisely to prevent this. After President Nixon unilaterally withheld billions in congressionally appropriated funds for housing, education, and environmental protection, Congress passed the ICA to establish that appropriated funds must be spent for their designated purpose. The president may propose deferrals (temporary delays) or rescissions (permanent cancellations), but Congress must approve rescissions within 45 days.

The current administration's position is that the president has inherent constitutional authority to decline to spend appropriated funds — a direct challenge to the ICA's framework. Courts have not definitively resolved the question, and in the meantime, appropriated dollars accumulate in agency accounts while award timelines stretch beyond what many organizations can survive.

What it means for you: Even if your agency's budget line survives intact, the timing of disbursement is no longer predictable. Organizations that cannot absorb three-to-six-month funding delays need reserves, bridge financing, or diversified revenue streams.

2. Pocket Rescissions: Running Out the Clock on Congressional Authority

If impoundment is the quiet version of withholding funds, pocket rescissions are the procedural version. Under the ICA, the president may propose rescinding appropriated funds and withhold them for up to 45 days while Congress considers the proposal. If Congress does not affirmatively approve the rescission within 45 days, the funds must be released.

A pocket rescission exploits the calendar. The executive transmits a rescission request so late in the fiscal year — typically with fewer than 45 days remaining before September 30 — that the funds expire before Congress can act. The money is never formally canceled. It simply runs out of time.

The Government Accountability Office has concluded that pocket rescissions are illegal under the ICA because they effectively cancel funds without Congressional approval. The Center on Budget and Policy Priorities describes them as "clearly illegal" and notes they represent "the first time that a President has sought to misuse the Impoundment Control Act to violate the Constitution by cancelling funds unilaterally without congressional action." Partners in Health called the mechanism "unconstitutional."

The administration disagrees. In 2025, the White House used a pocket rescission to withhold and cancel congressionally appropriated foreign aid and public broadcasting funding. As the National League of Cities warned, the administration's position that pocket rescissions are legal means "Congressional appropriations bills could no longer be the last word on program funding levels."

For domestic grant programs, the implication is profound. Any program the administration wants to defund but Congress insists on funding could be targeted with a late-fiscal-year rescission request. Even if the rescission fails — even if courts eventually rule it illegal — the 45-day hold and the bureaucratic uncertainty surrounding it can effectively kill a full grant cycle.

What it means for you: Programs the administration has repeatedly proposed for elimination — CDBG, CSBG, environmental justice, STEM education — face the highest rescission risk even after Congress funds them. Monitor the OMB rescission calendar, particularly in July through September.

3. Termination for Convenience: The Clause That Can Kill Any Discretionary Grant

Executive Order 14332, signed in August 2025, established a framework for what the administration calls "improving oversight of federal grantmaking." In practice, it created a mechanism for agencies to review, restructure, or terminate existing discretionary grants based on alignment with administration priorities.

The most consequential change came through new HHS grant terms and conditions effective October 1, 2025, which allow agencies to "take steps to revise the terms and conditions of existing discretionary grants to permit immediate termination for convenience." Termination for convenience is a standard contract provision that allows either party to end an agreement without cause. Historically, it was invoked in unusual circumstances — a program being restructured, an agency reorganizing. Under the new framework, it has become a tool for ending grants that the executive branch considers misaligned with its policy agenda, regardless of whether the grantee has met all performance requirements.

The mechanism works like this: an agency reviews its existing discretionary grant portfolio, identifies awards that do not align with current priorities, and terminates them by invoking the convenience clause. The grantee receives minimal notice. There is no appeals process equivalent to what exists for termination for cause. And because the grants were already awarded and partially executed, the organizations that received them may have already hired staff, committed to subcontractors, and made expenditures that cannot be reversed.

The National Health Council reported that the new compliance environment includes "expanded grant certifications and organizational reviews," "stricter restrictions on whom grant programs can serve," and "increased vulnerability to False Claims Act investigations." Organizations that fail to align their language, certifications, and program descriptions with administration priorities face not just defunding but potential legal liability.

What it means for you: Review every active federal grant for termination-for-convenience clauses. As Granted has reported on EO 14332, the language of your grant application — not just its substance — now matters for survival. Avoid terminology the administration has flagged. Ensure your organization's certifications, particularly the SAM.gov registration, are current and compliant with the latest requirements.

4. Forward Funding: The Math That Eliminates 970 Grants

The subtlest mechanism is also one of the most damaging. In FY2026, NIH implemented a forward-funding mandate requiring that multiyear grants be funded with a single upfront lump sum rather than the traditional annual disbursement.

Under the old system, a five-year R01 grant budgeted at $500,000 per year would draw $500,000 from the current fiscal year's appropriation, with future years funded from future appropriations. Under forward funding, the same grant requires $2.5 million from the current year's budget — consuming five times as much of this year's available funding.

The arithmetic is devastating. NIH's own projections estimate that the forward-funding mandate will eliminate approximately 970 competing grants in FY2026 alone. Not because Congress cut the budget. Not because applications were weaker. Simply because the same pool of money, distributed in larger per-award chunks, supports fewer total awards.

NIH success rates have dropped to approximately 17 percent — the lowest in nearly three decades, down from 26 percent the prior year. For early-stage investigators, the success rate fell from 29.8 percent in FY2023 to 18.5 percent in FY2025. These numbers reflect a funding system that is being squeezed from every direction: flat budgets, forward-funding mandates, and processing delays all compounding simultaneously.

The mechanism is not limited to NIH. Any agency that adopts forward-funding policies for multiyear awards — a possibility the administration has signaled for DOE and NSF — would face the same arithmetic. The same appropriation. Fewer grants.

What it means for you: Multiyear grant seekers should model the forward-funding impact on their target agencies. Smaller, shorter-duration awards (R21s, supplements, planning grants) may face less forward-funding pressure than large multiyear mechanisms. Agencies that have not adopted forward funding — DOD, USDA, some DOE offices — become relatively more attractive.

5. Staff Collapse: No One Left to Process the Awards

The final mechanism is the most mundane and potentially the most destructive. Federal agencies have lost the human capacity to process grants at historical rates.

NIH has lost over 4,000 employees — approximately 20 percent of its workforce — in the past year. NSF's biology directorate has 40 percent fewer program officers. Across NSF, hundreds of "rotators" — scientists on loan from academia who served as program managers — were eliminated. As of March 15, 2026, NIH had published only 14 Notices of Funding Opportunities for the calendar year, compared to 756 in all of 2024 — a 98 percent reduction.

As Granted has reported, over 95,000 federal employees across grant-making agencies have departed through Reductions in Force, voluntary buyouts, and attrition. The Office of Management and Budget freeze on federal hiring has prevented agencies from replacing departures. Grant review panels that once had five members now have two. Review summaries that ran a full page are now compressed to three to five sentences. Application processing timelines have stretched from 90 days to six months or longer.

The staff collapse creates a cascade. Fewer program officers means fewer notices of funding opportunity. Fewer NOFOs means fewer applications reviewed. Fewer reviews means fewer awards. And for the awards that are made, fewer staff means longer processing, slower disbursement, and less technical assistance — all of which degrade the quality and impact of the research and programs the grants are supposed to support.

What it means for you: Build longer timelines into your funding projections. If your agency's program officers have departed, reach out to whoever has assumed the portfolio — relationships with overworked staff are more valuable than ever. Consider agencies that have retained more capacity, such as DOD, which has been partially shielded from civilian staffing cuts by its defense mission.

The Unified Threat — and the Strategic Response

These five mechanisms are not independent. They reinforce each other. Impoundment delays funds. Staff losses slow processing of whatever funds are released. Forward funding reduces the number of awards from the same budget. Termination for convenience allows cancellation of awards already made. And pocket rescissions threaten to cancel the funds themselves before they expire.

For a researcher, nonprofit, or small business that depends on federal grants, the practical implication is that the Congressional budget number is now the ceiling, not the floor. The actual amount of funding that reaches grantees will be some fraction of the appropriated total — reduced by each mechanism in succession.

The strategic response is straightforward but demanding:

Diversify funding sources. Organizations that depend on a single federal agency for more than 40 percent of their revenue face existential risk. State agencies, private foundations, industry partnerships, and international funders are all partial substitutes. None is a perfect replacement, but a portfolio approach reduces the probability that any single mechanism can be fatal.

Maintain compliance rigor. Termination for convenience targets grants that can be characterized as misaligned with agency priorities. Airtight compliance, precise language, and proactive communication with program officers reduce the surface area for adverse action.

Build reserves. The temporal uncertainty created by impoundment, processing delays, and pocket rescissions means that organizations need three to six months of operating reserves to bridge funding gaps that did not exist two years ago.

Track the mechanisms, not just the headlines. The budget number is the beginning of the story, not the end. Monitor OMB rescission proposals, agency staffing announcements, forward-funding policy changes, and grant terms and conditions. Platforms like Granted can help track funding opportunities across agencies and build applications that are resilient to the compliance environment — because in 2026, winning the grant is only half the battle.